Date Item Type Full Text Status

1 July 2018

Baricitinib for previously treated moderate or severe rheumatoid arthritis: : An Evidence Review Group perspective of a NICE Single Technology Appraisal. (2018) S Ren, Iñigo Bermejo, Emma L Simpson, R. Wong, D Scott, Keith Young and Matt D Stevenson